ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I. Cardiogenic Shock
ECMO for Shock in Acute MI Won't Help, May Harm: ECLS-SHOCK https://www.medscape.com/viewarticle/995882
- ECLS-SHOCK trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307227
- ECMO-CS trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.062949
II. FIRE TRIAL
FIRE a Win for Physiology-Guided MI Complete Revascularization in Older Patients https://www.medscape.com/viewarticle/995875
- FIRE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2300468
- COMPLETE Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1907775
III. Immediate vs Staged Revascularization
Parity for Prompt vs Staged STEMI Complete Revascularization: MULTISTARS-AMI https://www.medscape.com/viewarticle/995961
- MULTISTARS AMI trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307823
- Complete Revascularization Now Compulsory? MULTISTARS-AMI and FIRE in Context https://www.medscape.com/viewarticle/995676
IV. Iron-Supplementation in Heart Failure
IV Iron Shows Only Modest Benefit in HF: HEART-FID https://www.medscape.com/viewarticle/995874
- HEART-FID https://www.nejm.org/doi/full/10.1056/NEJMoa2304968
- EHJ meta-analysis of Iron Supplementation https://doi.org/10.1093/eurheartj/ehad586
V. AF Prevention with Pacing
Minimizing Atrial Pacing No Benefit in Sinus Node Disease: DANPACE II https://www.medscape.com/viewarticle/996076
- DANPACE II https://doi.org/10.1093/eurheartj/ehad564
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine. https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]